【科笛-B(02487.HK)：CU-30101(局部外用利多卡因丁卡因乳膏剂)中国III期临床试验结果获第30次CSD年会接受以电子壁报形式展示】智通财经APP讯，科笛-B(02487.HK)发布公告，该集团用于表皮麻醉手术的CU-30101(局部外用利多卡因丁卡因乳膏剂)的中国III期临床试验(“该III期临床试验”)结果获中华医学会第30次皮肤性病学术年会(“CSD年会”)接受以电子壁报形式展示。这是本集团的研究成果连续两届入选CSD年会，代表了本集团在皮肤科领域的行业影响力及前沿水准。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.